Barclays PLC trimmed its stake in RXO, Inc. (NYSE:RXO – Free Report) by 68.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 285,194 shares of the company’s stock after selling 623,679 shares during the quarter. Barclays PLC’s holdings in RXO were worth $6,798,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Wilmington Savings Fund Society FSB purchased a new position in RXO in the 3rd quarter valued at about $28,000. Blue Trust Inc. raised its position in shares of RXO by 79.7% in the fourth quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock valued at $27,000 after buying an additional 510 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of RXO by 228.4% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company’s stock valued at $30,000 after buying an additional 868 shares during the period. Thurston Springer Miller Herd & Titak Inc. boosted its position in RXO by 407.0% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock worth $43,000 after acquiring an additional 1,445 shares during the last quarter. Finally, KBC Group NV grew its stake in RXO by 41.2% in the 4th quarter. KBC Group NV now owns 5,727 shares of the company’s stock worth $137,000 after acquiring an additional 1,672 shares during the period. 92.73% of the stock is currently owned by hedge funds and other institutional investors.
RXO Price Performance
Shares of RXO stock opened at $14.09 on Friday. RXO, Inc. has a twelve month low of $12.19 and a twelve month high of $32.82. The company has a market capitalization of $2.31 billion, a PE ratio of -6.64, a price-to-earnings-growth ratio of 4.55 and a beta of 1.60. The company has a current ratio of 1.26, a quick ratio of 1.33 and a debt-to-equity ratio of 0.22. The firm has a fifty day simple moving average of $17.43 and a 200-day simple moving average of $23.44.
Analyst Ratings Changes
Several research firms recently weighed in on RXO. Morgan Stanley reduced their target price on RXO from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 6th. Oppenheimer cut shares of RXO from an “outperform” rating to a “market perform” rating in a research note on Friday, April 4th. Citigroup cut their target price on RXO from $23.00 to $15.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 8th. Wells Fargo & Company lowered their price target on RXO from $22.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday, March 27th. Finally, Barclays reduced their price objective on RXO from $24.00 to $22.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 2nd. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $22.40.
About RXO
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Featured Stories
- Five stocks we like better than RXO
- What is the Dow Jones Industrial Average (DJIA)?
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- Investing in the High PE Growth Stocks
- Why Smart Investors Don’t Panic in Election Season
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RXO, Inc. (NYSE:RXO – Free Report).
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.